• 5-Azacytidine: Mechanistic Insights and Translational Levera

  2026-04-22

  Explore the advanced mechanistic actions of 5-Azacytidine in multiple myeloma research. This article uncovers how ATR-mediated DNA damage and apoptosis induction set this DNA demethylation agent apart, offering actionable protocols and practical guidance for epigenetic and oncology studies.

• iPSC-Derived Airway Models Advance Cystic Fibrosis Drug Rese

  2026-04-22

  This study presents a multimodal platform using iPSC-derived airway epithelial cells to model cystic fibrosis across diverse CFTR genetic variants. By adapting established functional assays for these cells, the research enables genotype-specific drug response analysis, offering a foundation for more precise therapeutic development.

• Tin Mesoporphyrin IX: Precision Inhibition in HO Activity As

  2026-04-21

  Tin Mesoporphyrin IX (chloride) empowers researchers to dissect heme oxygenase biology with nanomolar precision—enabling advanced metabolic, redox, and viral studies beyond standard inhibitor toolkits. This guide translates latest reference findings and troubleshooting tactics into actionable workflows, maximizing reproducibility and insight for metabolic disease and infection models.

• Atorvastatin: HMG-CoA Reductase Inhibitor for Advanced Resea

  2026-04-21

  Atorvastatin is transforming cholesterol metabolism and oncology research by enabling precise modulation of cellular pathways and ferroptosis induction. This guide delivers actionable workflows, experimental parameters, and troubleshooting insights for leveraging APExBIO’s Atorvastatin in cardiovascular and cancer models.

• BV6 IAP Antagonist: Precision Tools for Apoptosis Modulation

  2026-04-20

  Explore how the selective IAP antagonist BV6 empowers translational researchers to precisely induce apoptosis, enhance radiosensitivity, and refine experimental models in cancer and endometriosis. This article bridges mechanistic insights and strategic guidance, contrasting bacterial evasion of programmed cell death with targeted therapeutic disruption, and provides protocol parameters, competitive context, and a forward-looking perspective.

• Strategic Dissection of MCL-1 in Cancer: A-1210477 in Focus

  2026-04-20

  This thought-leadership article synthesizes the canonical role of MCL-1 in cancer cell survival with actionable insights for translational researchers. It highlights the mechanistic rationale for targeting MCL-1, experimental strategies using the selective MCL-1 inhibitor A-1210477, and the implications for cancer therapy innovation. Building on recent landmark studies and scenario-driven guidance, the discussion bridges mechanistic depth and strategic foresight—delivering a resource that surpasses standard product content in both evidence integration and translational impact.

• Optimizing hiPSC-Derived Platelet Production with Small Mole

  2026-04-19

  This study introduces an optimized protocol for the differentiation of functional platelets from human induced pluripotent stem cells (hiPSCs), significantly improving yield and reducing costs. The approach employs higher embryoid body cell input, a tailored serum-free medium, and strategic use of small molecules, with broad implications for scalable platelet biomanufacturing.

• Inhaled Risedronate Sodium Microspheres Induce Macrophage Ap

  2026-04-18

  This study demonstrates that nebulized Risedronate Sodium-chitosan microspheres effectively induce apoptosis in alveolar macrophages, leading to the attenuation of elastase-induced pulmonary emphysema in rats. The findings highlight a novel, inhalable delivery route for a classic FPP synthase inhibitor, enabling targeted modulation of lung inflammation and providing a foundation for translational research in emphysema therapy.

• Technical Guide: Calpain Inhibitor I, ALLN for Apoptosis Ass

  2026-04-17

  Calpain Inhibitor I, ALLN is a high-purity, cell-permeable inhibitor targeting calpain and cathepsin proteases, suited for apoptosis and ischemia-reperfusion injury research. It is not intended for diagnostic or therapeutic use and should not be used where direct clinical or in vivo human data are required.

• HDAC Inhibition Reverses EBV-Induced Dedifferentiation in NP

  2026-04-16

  This study uncovers how Epstein-Barr virus (EBV) promotes dedifferentiation and cellular plasticity in nasopharyngeal carcinoma (NPC) via HDAC-mediated repression of CEBPA. The authors demonstrate that HDAC inhibitors can restore differentiation in NPC models, providing mechanistic evidence for epigenetic targeting of tumor cell plasticity.

• Phosbind Biotin: Enabling Sequence-Independent Phosphorylati

  2026-04-15

  Explore how Phosbind Biotin leverages dinuclear metal complex phosphate binding for advanced, sequence-independent Western Blot detection of phosphorylated proteins. This article uniquely examines its mechanistic advantages and translational impact in signal transduction research.

• L1023 Anti-Cancer Compound Library: Evidence, Use, and Limit

  2026-04-14

  The L1023 Anti-Cancer Compound Library provides 1,164 well-characterized, cell-permeable compounds for high-throughput screening of anti-cancer agents. This resource is validated for targeting multiple oncogenic pathways and supports research into molecular mechanisms such as BRAF and mTOR inhibition. Its quality and utility are supported by peer-reviewed evidence and robust analytical validation.

• Plant Exosome-Like Nanovesicles Mitigate Chemotherapy-Induce

  2026-04-13

  This study demonstrates that exosome-like nanovesicles derived from Cistanche deserticola (CDELNs) can alleviate cyclophosphamide-induced testicular injury by targeting cell cycle arrest in Sertoli cells. The findings reveal a novel mechanism involving miRNA-mediated regulation of P21, suggesting a promising strategy for protecting male fertility during chemotherapy.

• 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine: Precision in S

  2026-04-12

  Leveraging 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP 3) as a negative control unlocks unparalleled specificity and reproducibility in Src kinase signaling pathway research. This guide details workflow enhancements, real-world troubleshooting, and actionable parameters to empower confident experimental design.

• Lipid Peroxidation (MDA) Assay Kit: Precision in Oxidative S

  2026-04-12

  The Lipid Peroxidation (MDA) Assay Kit (SKU: K2167) empowers researchers to achieve robust, quantitative analysis of malondialdehyde—a key oxidative stress biomarker—with both colorimetric and fluorescence readouts. This detailed guide bridges protocol best practices, troubleshooting strategies, and translational research insights from the latest ccRCC ferroptosis studies to maximize assay performance and interpretive power.

455 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page